B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
about
Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies.Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies.B7-H3 role in the immune landscape of cancer.B7-H3 in tumors: friend or foe for tumor immunity?Reduced sB7-H3 Expression in the Peripheral Blood of Systemic Lupus Erythematosus Patients.Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.B7H3 As a Promoter of Metastasis and Promising Therapeutic TargetTargeting immunotherapy for bladder cancer using anti-CD3× B7-H3 bispecific antibody
P2860
Q34548319-42688D49-A1BC-4A97-A359-3062EB22BB1CQ38670099-63209B69-43F2-408C-9DB7-597BF9CA14E3Q39427326-F1761233-6032-4F18-8601-F1D53973A7E6Q47233613-F852BFB7-25A5-436A-AFC1-795780D1A6F7Q49176886-432B507E-3D66-43B2-B103-5B85A74F5324Q49981787-9A57E0CF-79D3-4C10-A9D8-FC5104FD1761Q57176931-AC936446-D8E2-4D05-8F32-216D17B4834CQ58697139-55AC5A85-4B6D-4F1F-9866-E69C905C6C40
P2860
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
@en
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
@nl
type
label
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
@en
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
@nl
prefLabel
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
@en
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
@nl
P2093
P2860
P356
P1433
P1476
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
@en
P2093
Changzhen Liu
Chenghai Zhao
Huamin Han
Weigang Xiu
P2860
P304
29480-29491
P356
10.18632/ONCOTARGET.8784
P407
P577
2016-04-18T00:00:00Z